11 May 2026 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today published advice on five medicines.

Enfortumab vedotin (Padcev) was accepted, when used with pembrolizumab, for the first-line treatment of adults with advanced bladder cancer.

Read SMC press release